Literature DB >> 1722929

Inhibition of human immunodeficiency virus replication in a human T cell line by antisense RNA expressed in the cell.

J Gyotoku1, M A el-Farrash, S Fujimoto, W T Germeraad, Y Watanabe, K Teshigawara, S Harada, Y Katsura.   

Abstract

The effect of the expression of antisense RNA against the human immunodeficiency virus (HIV) genome in a human T-cell line CEM on HIV replication was investigated. A 2.7 kilobase (kb) fragment of the HIV genome, including tat and a part of rev and env, was cloned into the retroviral vector WB in the antisense orientation under the SV40 or H-2K promoter. CEM cells transduced with this antisense gene via recombinant retrovirus expressed the RNAs of three different molecular sizes containing the antisense construct. CEM cells and these transduced cells were infected with HIV. HIV replication was evaluated 4-10 days later by an immunofluorescence assay and by determining the reverse transcriptase activity in the culture supernatant. The results indicate that although the recombinant retrovirus WB strongly enhanced the HIV replication in CEM cells, the expression of antisense RNA in the cells was highly effective in impeding the replication of HIV. The inhibitory effect was especially high in CEM cells transduced with the antisense gene under the control of SV40 promoter. In this case, HIV antigen-positive cells and reverse transcriptase activity in the culture supernatant of transduced cells were reduced to 30-50% and 5-10% of those in CEM cells and in the CEM cells transduced with WB, respectively.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1722929     DOI: 10.1007/bf00568969

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  43 in total

1.  Antisense oligodeoxynucleotides provide insight into mechanism of translation initiation of two Sendai virus mRNAs.

Authors:  K C Gupta
Journal:  J Biol Chem       Date:  1987-06-05       Impact factor: 5.157

Review 2.  The role of antisense RNA in gene regulation.

Authors:  P J Green; O Pines; M Inouye
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

Review 3.  Regulation of HIV and HTLV gene expression.

Authors:  H Varmus
Journal:  Genes Dev       Date:  1988-09       Impact factor: 11.361

4.  Effect of heat and fresh human serum on the infectivity of human T-cell lymphotropic virus type III evaluated with new bioassay systems.

Authors:  S Harada; H Yoshiyama; N Yamamoto
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

5.  Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production.

Authors:  A D Miller; C Buttimore
Journal:  Mol Cell Biol       Date:  1986-08       Impact factor: 4.272

6.  Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hemopoietic system of W/Wv mice.

Authors:  J E Dick; M C Magli; D Huszar; R A Phillips; A Bernstein
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

7.  A cytological study of the capacity for differentiation of normal hemopoietic colony-forming cells.

Authors:  A M Wu; J E Till; L Siminovitch; E A McCulloch
Journal:  J Cell Physiol       Date:  1967-04       Impact factor: 6.384

8.  Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus.

Authors:  S Agrawal; J Goodchild; M P Civeira; A H Thornton; P S Sarin; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

9.  Purification and characterization of mouse hematopoietic stem cells.

Authors:  G J Spangrude; S Heimfeld; I L Weissman
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728

10.  Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS.

Authors:  J A Levy; A D Hoffman; S M Kramer; J A Landis; J M Shimabukuro; L S Oshiro
Journal:  Science       Date:  1984-08-24       Impact factor: 47.728

View more
  3 in total

1.  Comparative analyses of intracellularly expressed antisense RNAs as inhibitors of human immunodeficiency virus type 1 replication.

Authors:  G Veres; U Junker; J Baker; C Barske; C Kalfoglou; H Ilves; S Escaich; H Kaneshima; E Böhnlein
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

2.  A new antisense tRNA construct for the genetic treatment of human immunodeficiency virus type 1 infection.

Authors:  M A Biasolo; A Radaelli; L Del Pup; E Franchin; C De Giuli-Morghen; G Palu
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

3.  Generation and characterization of a human immunodeficiency virus type 1 (HIV-1) mutant resistant to an HIV-1 protease inhibitor.

Authors:  M A el-Farrash; M J Kuroda; T Kitazaki; T Masuda; K Kato; M Hatanaka; S Harada
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.